670 related articles for article (PubMed ID: 8538742)
1. A role for glucagon-like peptide-1 in the central regulation of feeding.
Turton MD; O'Shea D; Gunn I; Beak SA; Edwards CM; Meeran K; Choi SJ; Taylor GM; Heath MM; Lambert PD; Wilding JP; Smith DM; Ghatei MA; Herbert J; Bloom SR
Nature; 1996 Jan; 379(6560):69-72. PubMed ID: 8538742
[TBL] [Abstract][Full Text] [Related]
2. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
4. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide containing pathways in the regulation of feeding behaviour.
Tang-Christensen M; Vrang N; Larsen PJ
Int J Obes Relat Metab Disord; 2001 Dec; 25 Suppl 5():S42-7. PubMed ID: 11840214
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1(7-36) amide's central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment.
Tang-Christensen M; Vrang N; Larsen PJ
Diabetes; 1998 Apr; 47(4):530-7. PubMed ID: 9568683
[TBL] [Abstract][Full Text] [Related]
7. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.
Schick RR; Zimmermann JP; vorm Walde T; Schusdziarra V
Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1427-35. PubMed ID: 12776726
[TBL] [Abstract][Full Text] [Related]
8. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
[TBL] [Abstract][Full Text] [Related]
9. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
Hayes MR; Bradley L; Grill HJ
Endocrinology; 2009 Jun; 150(6):2654-9. PubMed ID: 19264875
[TBL] [Abstract][Full Text] [Related]
10. Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.
Thiele TE; Seeley RJ; D'Alessio D; Eng J; Bernstein IL; Woods SC; van Dijk G
Brain Res; 1998 Aug; 801(1-2):164-70. PubMed ID: 9729361
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro.
Dalvi PS; Nazarians-Armavil A; Purser MJ; Belsham DD
Endocrinology; 2012 May; 153(5):2208-22. PubMed ID: 22334721
[TBL] [Abstract][Full Text] [Related]
12. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
Tang-Christensen M; Larsen PJ; Göke R; Fink-Jensen A; Jessop DS; Møller M; Sheikh SP
Am J Physiol; 1996 Oct; 271(4 Pt 2):R848-56. PubMed ID: 8897973
[TBL] [Abstract][Full Text] [Related]
13. Importance of orexigenic counter-regulation for multiple targeted feeding inhibition.
Schusdziarra V; Zimmermann JP; Schick RR
Obes Res; 2004 Apr; 12(4):627-32. PubMed ID: 15090630
[TBL] [Abstract][Full Text] [Related]
14. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat.
Meeran K; O'Shea D; Edwards CM; Turton MD; Heath MM; Gunn I; Abusnana S; Rossi M; Small CJ; Goldstone AP; Taylor GM; Sunter D; Steere J; Choi SJ; Ghatei MA; Bloom SR
Endocrinology; 1999 Jan; 140(1):244-50. PubMed ID: 9886831
[TBL] [Abstract][Full Text] [Related]
15. Separation of emetic and anorexic responses of exendin-4, a GLP-1 receptor agonist in Suncus murinus (house musk shrew).
Chan SW; Lin G; Yew DT; Yeung CK; Rudd JA
Neuropharmacology; 2013 Jul; 70():141-7. PubMed ID: 23357334
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.
Dossat AM; Lilly N; Kay K; Williams DL
J Neurosci; 2011 Oct; 31(41):14453-7. PubMed ID: 21994361
[TBL] [Abstract][Full Text] [Related]
17. Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain.
Van Dijk G; Thiele TE; Donahey JC; Campfield LA; Smith FJ; Burn P; Bernstein IL; Woods SC; Seeley RJ
Am J Physiol; 1996 Oct; 271(4 Pt 2):R1096-100. PubMed ID: 8898006
[TBL] [Abstract][Full Text] [Related]
18. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
19. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Diabetes; 2004 Sep; 53(9):2492-500. PubMed ID: 15331566
[TBL] [Abstract][Full Text] [Related]
20. The hypothalamus is involved in the anorexic effect of glucagon-like peptide-1 in chicks.
Tachibana T; Hirofuji K; Matsumoto M; Furuse M; Hasegawa S; Yoshizawa F; Sugahara K
Comp Biochem Physiol A Mol Integr Physiol; 2004 Jan; 137(1):183-8. PubMed ID: 14720603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]